跳至主要内容
临床试验/NCT00491140
NCT00491140已完成不适用

Retrospective Study Assessing Molecular Features Predicting Response or Resistance to Cetuximab Therapy in Metastatic Colorectal Cancer Patients

Istituto Clinico Humanitas1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2006年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
85
试验地点
1
主要终点
Association of different biomarkers with Cetuximab sensitivity

研究概览

简要总结

The primary objective is to identify molecular features predicting response or resistance to cetuximab

详细描述

Secondary objective is to investigate association of genomic status of EGFR and HER-2 genes with clinical outcome, including objective response, time to progression and survival

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed diagnosis of colorectal cancer with available tumor tissue and clinical data; presence of at least one measurable lesion.

排除标准

  • Less than 3 weeks after completion of previous radiotherapy

结局指标

主要结局

Association of different biomarkers with Cetuximab sensitivity

时间窗: Assessment every two months

次要结局

  • Association of different biomarkers with time to progression and survival(At the end of the study)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other

研究点 (1)

Loading locations...

相似试验